99% Savings - Buy Just @1 Rs X
Diligan CD is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Diligan CD safe for pregnant women?
There are no side effects of Diligan CD in pregnant women.
Is the use of Diligan CD safe during breastfeeding?
Diligan CD can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Diligan CD on the Kidneys?
Diligan CD rarely harms the kidneys.
What is the effect of Diligan CD on the Liver?
Side effects of Diligan CD rarely affect the liver.
What is the effect of Diligan CD on the Heart?
Diligan CD is rarely harmful for the heart.
Diligan CD should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Diligan CD unless your doctor advises you to do so -
Is this Diligan CD habit forming or addictive?
No, you will not get addicted to Diligan CD .
Interaction between Food and Diligan CD
Taking Diligan CD with food does not cause any problems.
Interaction between Alcohol and Diligan CD
Taking Diligan CD with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tekturna® (aliskiren)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 508
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663